Integrating exome sequencing into a diagnostic pathway for epileptic encephalopathy: Evidence of clinical utility and cost effectiveness-Reference-Cited by-同舟云学术

Integrating exome sequencing into a diagnostic pathway for epileptic encephalopathy: Evidence of clinical utility and cost effectiveness

Published:2018-01-04 Issue:2 Volume:6 Page:186-199
ISSN:2324-9269
Container-title:Molecular Genetics & Genomic Medicine
language:en
Short-container-title:Mol Genet Genomic Med

Author:

Palmer Elizabeth E.¹²³⁴^ORCID,Schofield Deborah⁴⁵⁶,Shrestha Rupendra⁵,Kandula Tejaswi¹²,Macintosh Rebecca¹,Lawson John A.¹²,Andrews Ian¹²,Sampaio Hugo¹²,Johnson Alexandra M.¹²,Farrar Michelle A.¹²,Cardamone Michael¹²,Mowat David¹²,Elakis George⁷,Lo William⁷,Zhu Ying³⁷,Ying Kevin⁴,Morris Paula⁴,Tao Jiang⁴⁸,Dias Kerith-Rae⁴,Buckley Michael⁷,Dinger Marcel E.⁴⁸,Cowley Mark J.⁴⁸,Roscioli Tony¹⁷,Kirk Edwin P.¹²⁷,Bye Ann¹²,Sachdev Rani K.¹²

Affiliation:

1. Sydney Children's Hospital; Randwick NSW Australia

2. School of Women's and Children's Health; UNSW Medicine; The University of New South Wales; Sydney NSW Australia

3. Genetics of Learning Disability Service; Waratah NSW Australia

4. The Garvan Institute for Medical Research; Darlinghurst, Sydney NSW Australia

5. Faculty of Pharmacy; The University of Sydney; Sydney NSW Australia

6. The Murdoch Children's Research Institute; Melbourne Vic. Australia

7. SEALS pathology; Randwick NSW Australia

8. St Vincent's Clinical School; University of New South Wales; Sydney NSW Australia

Funder

Kinghorn Foundation

National Health and Medical Research Council